Search Results - "Tomatsu, S"

Refine Results
  1. 1

    Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA by Hendriksz, C.J., Harmatz, P., Beck, M., Jones, S., Wood, T., Lachman, R., Gravance, C.G., Orii, T., Tomatsu, S.

    Published in Molecular genetics and metabolism (01-09-2013)
    “…Mucopolysaccharidosis type IVA (MPS IVA) was described in 1929 by Luis Morquio from Uruguay and James Brailsford from England, and was later found as an…”
    Get full text
    Journal Article
  2. 2

    International Morquio A Registry: Clinical manifestation and natural course of Morquio A disease by Montaño, A. M., Tomatsu, S., Gottesman, G. S., Smith, M., Orii, T.

    Published in Journal of inherited metabolic disease (01-04-2007)
    “…Summary Mucopolysaccharidosis IVA (MPS IVA; Morquio A disease) is a lysosomal storage disorder caused by deficiency of N‐acetylgalactosamine‐6‐sulfate…”
    Get full text
    Journal Article
  3. 3

    Effect of ‘attenuated' mutations in mucopolysaccharidosis IVA on molecular phenotypes of N-acetylgalactosamine-6-sulfate sulfatase by Montaño, A. M, Sukegawa, K, Kato, Z, Carrozzo, R, Di Natale, P, Christensen, E, Orii, K. O, Orii, T, Kondo, N, Tomatsu, S

    Published in Journal of inherited metabolic disease (01-10-2007)
    “…Mucopolysaccharidosis IVA is an autosomal recessive disease caused by the deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS). Mutation screening…”
    Get full text
    Journal Article
  4. 4

    Effect of Hunter disease (mucopolysaccharidosis type II) mutations on molecular phenotypes of iduronate‐2‐sulfatase: Enzymatic activity, protein processing and structural analysis by Sukegawa‐Hayasaka, K., Kato, Z., Nakamura, H., Tomatsu, S., Fukao, T., Kuwata, K., Orii, T., Kondo, N.

    Published in Journal of inherited metabolic disease (01-12-2006)
    “…Summary Mucopolysaccharidosis II (Hunter disease), a lysosomal storage disorder caused by a deficiency of iduronate‐2‐sulfatase (IDS), has variable clinical…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Production of MPS VII mouse (Gustm(hE540A·mE536A)Sly) doubly tolerant to human and mouse β-glucuronidase by Tomatsu, Shunji, Orii, Koji O., Vogler, Carole, Grubb, Jeffrey H., Snella, Elizabeth M., Gutierrez, Monica, Dieter, Tatiana, Holden, Christopher C., Sukegawa, Kazuko, Orii, Tadao, Kondo, Naomi, Sly, William S.

    Published in Human molecular genetics (01-05-2003)
    “…Mucopolysaccharidosis VII (MPS VII, Sly syndrome) is an autosomal recessive lysosomal storage disease caused by β-glucuronidase (GUS) deficiency. A naturally…”
    Get full text
    Journal Article
  10. 10

    GALNS gene expression profiling in Morquio A patients' fibroblasts by Carraresi, L., Parini, R., Filoni, C., Caciotti, A., Sersale, G., Tomatsu, S., Orlando, C., Zammarchi, E., Guerrini, R., Donati, M.A., Morrone, A.

    Published in Clinica chimica acta (01-11-2008)
    “…Quantification studies of mutated mRNAs have not been carried out on Morquio A patients. Such studies are very important for the determination of stability of…”
    Get full text
    Journal Article
  11. 11

    Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation by YAMADA, Y, KATO, K, ORII, T, SUKEGAWA, K, TOMATSU, S, FUKUDA, S, EMURA, S, KOJIMA, S, MATSUYAMA, T, SLY, W. S, KONDO, N

    Published in Bone marrow transplantation (Basingstoke) (01-03-1998)
    “…A 12-year-old girl with Sly disease (mucopolysaccharidosis VII; beta-glucuronidase deficiency), who is homozygous for the A619V mutation, had a successful…”
    Get full text
    Journal Article
  12. 12

    Various cells retrovirally transduced with N-acetylgalactosoamine-6-sulfate sulfatase correct Morquio skin fibroblasts in vitro by Toietta, G, Severini, G M, Traversari, C, Tomatsu, S, Sukegawa, K, Fukuda, S, Kondo, N, Tortora, P, Bordignon, C

    Published in Human gene therapy (01-11-2001)
    “…Gene therapy may provide a long-term approach to the treatment of mucopolysaccharidoses. As a first step toward the development of an effective gene therapy…”
    Get more information
    Journal Article
  13. 13

    Human peroxisome assembly factor-2 (PAF-2) : A gene responsible for group C peroxisome biogenesis disorder in humans by FUKUDA, S, SHIMOZAWA, N, KUROKI, Y, FUJIKI, Y, ORII, T, KONDO, N, SUZUKI, Y, ZHANG, Z, TOMATSU, S, TSUKAMOTO, T, HASHIGUCHI, N, OSUMI, T, MASUNO, M, IMAIZUMI, K

    Published in American journal of human genetics (01-12-1996)
    “…Peroxisome-biogenesis disorders (PBD) are genetically heterogeneous and can be classified into at least ten complementation groups. We recently isolated the…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Buddhist Care for the Dying and Bereaved by Watts, Jonathan, Tomatsu , Yoshiharu

    Published 2012
    “…Since its beginning, Buddhism has been intimately concerned with confronting and understanding death and dying. Indeed, the tradition emphasizes turning toward…”
    Get full text
    eBook
  16. 16

    Overexpression rescues the mutant phenotype of L176F mutation causing beta-glucuronidase deficiency mucopolysaccharidosis in two Mennonite siblings by Wu, B M, Tomatsu, S, Fukuda, S, Sukegawa, K, Orii, T, Sly, W S

    Published in The Journal of biological chemistry (23-09-1994)
    “…Two beta-glucuronidase-deficient Mennonite siblings were found to be homozygous for a mutation in exon 3 of the beta-glucuronidase gene that produces a…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Mutation analysis in the iduronate‐2‐sulphatase gene in 43 Japanese patients with mucopolysaccharidosis type II (Hunter disease) by Isogai, K., Sukegawa, K., Tomatsu, S., Fukao, T., Song, X‐Q., Yamada, Y., Fukuda, S., Orii, T., Kondo, N.

    Published in Journal of inherited metabolic disease (01-02-1998)
    “…Our series of studies on Hunter disease in Japanese patients showed allelic heterogeneity of IDS gene mutations, genotype/phenotype correlation and racial…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Identification of a nonsense mutation in ALD protein cDNA from a patient with adrenoleukodystrophy by Uchiyama, A, Suzuki, Y, Song, X Q, Fukao, T, Imamura, A, Tomatsu, S, Shimozawa, N, Kondo, N, Orii, T

    “…The molecular basis of X-linked adrenoleukodystrophy (ALD) was investigated. Six (A to 50) fragments of cDNA for ALD protein (Mosser et al. Nature 361:…”
    Get more information
    Journal Article